Tissue Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Tissue Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

The global tissue diagnostics market size reached US$ 5.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.8% during 2023-2028.

Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.

Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue diagnostics market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product type, technology, disease and end-user.

Breakup by Product Type:

Instruments
Consumables

Breakup by Technology:

Immunohistochemistry
In Situ Hybridization
Digital Pathology and Workflow Management
Special Staining

Breakup by Disease:

Breast Cancer
Gastric Cancer
Lymphoma
Prostate Cancer
Non-Small Cell Lung Cancer
Others

Breakup by End-User:

Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Others

Breakup by Region:

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc

Key Questions Answered in This Report:
How has the global tissue diagnostics market performed so far and how will it perform in the coming years?
What are the key regional markets in the global tissue diagnostics industry?
What has been the impact of COVID-19 on the global tissue diagnostics industry?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the disease?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the global tissue diagnostics industry?
What are the key driving factors and challenges in the global tissue diagnostics industry?
What is the structure of the global tissue diagnostics industry and who are the key players?
What is the degree of competition in the global tissue diagnostics industry?
What are the profit margins in the global tissue diagnostics industry?